Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · IEX Real-Time Price · USD
-0.125 (-5.75%)
At close: Jul 17, 2024, 4:00 PM
-0.030 (-1.46%)
After-hours: Jul 17, 2024, 7:55 PM EDT

PACB Revenue

Pacific Biosciences of California had revenue of $200.43M in the twelve months ending March 31, 2024, with 49.54% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $38.81M. In the year 2023, Pacific Biosciences of California had annual revenue of $200.52M with 56.29% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
558.33M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 202078.89M-12.00M-13.20%
Dec 31, 201990.89M12.27M15.60%
Dec 31, 201878.63M-14.84M-15.88%
Dec 31, 201793.47M2.75M3.04%
Dec 31, 201690.71M-2.07M-2.23%
Dec 31, 201592.78M32.19M53.12%
Dec 31, 201460.59M32.41M115.02%
Dec 31, 201328.18M2.20M8.46%
Dec 31, 201225.98M-7.88M-23.27%
Dec 31, 201133.86M32.19M1,922.88%
Dec 31, 20101.67M1.54M1,140.00%
Dec 31, 2009135.00K-766.00K-85.02%
Dec 31, 2008901.00K-1.26M-58.34%
Dec 31, 20072.16M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pharming Group 280.83M
National Research 147.42M
Surmodics 142.96M
Alector 96.41M
IRadimed 67.69M
Jin Medical International 19.82M
Revenue Rankings